BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10355766)

  • 1. Recombinant Semliki Forest virus particles encoding the prME or NS1 proteins of louping ill virus protect mice from lethal challenge.
    Fleeton MN; Sheahan BJ; Gould EA; Atkins GJ; Liljestr M P
    J Gen Virol; 1999 May; 80 ( Pt 5)():1189-1198. PubMed ID: 10355766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A recombinant Semliki Forest virus particle vaccine encoding the prME and NS1 proteins of louping ill virus is effective in a sheep challenge model.
    Morris-Downes MM; Sheahan BJ; Fleeton MN; Liljeström P; Reid HW; Atkins GJ
    Vaccine; 2001 Jul; 19(28-29):3877-84. PubMed ID: 11427261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine.
    Fleeton MN; Liljeström P; Sheahan BJ; Atkins GJ
    J Gen Virol; 2000 Mar; 81(Pt 3):749-58. PubMed ID: 10675413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of baculovirus expressed recombinant proteins of Japanese encephalitis virus in mice.
    Yang DK; Kweon CH; Kim BH; Lim SI; Kwon JH; Kim SH; Song JY; Han HR
    J Vet Sci; 2005 Jun; 6(2):125-33. PubMed ID: 15933432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic potential and antigenic properties of recombinant tick-borne encephalitis virus subviral particles expressed in mammalian cells from Semliki Forest virus replicons.
    Levanov L; Kuivanen S; Matveev A; Swaminathan S; Jääskeläinen-Hakala A; Vapalahti O
    J Clin Microbiol; 2014 Mar; 52(3):814-22. PubMed ID: 24371235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant, chimaeric live, attenuated vaccine (ChimeriVax) incorporating the envelope genes of Japanese encephalitis (SA14-14-2) virus and the capsid and nonstructural genes of yellow fever (17D) virus is safe, immunogenic and protective in non-human primates.
    Monath TP; Soike K; Levenbook I; Zhang ZX; Arroyo J; Delagrave S; Myers G; Barrett AD; Shope RE; Ratterree M; Chambers TJ; Guirakhoo F
    Vaccine; 1999 Apr; 17(15-16):1869-82. PubMed ID: 10217584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-replicative RNA vaccines elicit protection against influenza A virus, respiratory syncytial virus, and a tickborne encephalitis virus.
    Fleeton MN; Chen M; Berglund P; Rhodes G; Parker SE; Murphy M; Atkins GJ; Liljeström P
    J Infect Dis; 2001 May; 183(9):1395-8. PubMed ID: 11294672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis C virus non-structural protein 3-specific cellular immune responses following single or combined immunization with DNA or recombinant Semliki Forest virus particles.
    Brinster C; Chen M; Boucreux D; Paranhos-Baccala G; Liljeström P; Lemmonier F; Inchauspé G
    J Gen Virol; 2002 Feb; 83(Pt 2):369-381. PubMed ID: 11807230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant Semliki Forest virus vector exhibits potential for avian virus vaccine development.
    Phenix KV; Wark K; Luke CJ; Skinner MA; Smyth JA; Mawhinney KA; Todd D
    Vaccine; 2001 Apr; 19(23-24):3116-23. PubMed ID: 11312006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant Semliki Forest virus vectors encoding hepatitis B virus small surface and pre-S1 antigens induce broadly reactive neutralizing antibodies.
    Niedre-Otomere B; Bogdanova A; Skrastina D; Zajakina A; Bruvere R; Ose V; Gerlich WH; Garoff H; Pumpens P; Glebe D; Kozlovska T
    J Viral Hepat; 2012 Sep; 19(9):664-73. PubMed ID: 22863271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis.
    Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS
    J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunologic analysis induced by DNA vaccine encoding E protein of Beijing-1 strain derived from Japanese encephalitis virus.
    Feng GH; Liu N; Zhou Y; Zhai YZ; Li XM; Dou XG
    Intervirology; 2007; 50(2):93-8. PubMed ID: 17139185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Basis of a Protective/Neutralizing Monoclonal Antibody Targeting Envelope Proteins of both Tick-Borne Encephalitis Virus and Louping Ill Virus.
    Yang X; Qi J; Peng R; Dai L; Gould EA; Gao GF; Tien P
    J Virol; 2019 Apr; 93(8):. PubMed ID: 30760569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunological basis for protection in a murine model of tick-borne encephalitis by a recombinant adenovirus carrying the gene encoding the NS1 non-structural protein.
    Timofeev AV; Ozherelkov SV; Pronin AV; Deeva AV; Karganova GG; Elbert LB; Stephenson JR
    J Gen Virol; 1998 Apr; 79 ( Pt 4)():689-95. PubMed ID: 9568962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naked RNA immunization with replicons derived from poliovirus and Semliki Forest virus genomes for the generation of a cytotoxic T cell response against the influenza A virus nucleoprotein.
    Vignuzzi M; Gerbaud S; van der Werf S; Escriou N
    J Gen Virol; 2001 Jul; 82(Pt 7):1737-1747. PubMed ID: 11413386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid Particles.
    Gullberg M; Lohse L; Bøtner A; McInerney GM; Burman A; Jackson T; Polacek C; Belsham GJ
    PLoS One; 2016; 11(6):e0157435. PubMed ID: 27294397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with the N-terminal region of the nonstructural protein NS1 promotes survival after challenge with lethal influenza A virus dose.
    Tamura M; Saikh KU; Kurane I; Ennis FA
    Viral Immunol; 1998; 11(3):131-5. PubMed ID: 9918404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccinia virus recombinant expressing gene of tick-borne encephalitis virus non-structural NS1 protein elicits protective activity in mice.
    Khoretonenko MV; Vorovitch MF; Zakharova LG; Pashvykina GV; Ovsyannikova NV; Stephenson JR; Timofeev AV; Altstein AD; Shneider AM
    Immunol Lett; 2003 Dec; 90(2-3):161-3. PubMed ID: 14687719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge.
    Schmaljohn C; Vanderzanden L; Bray M; Custer D; Meyer B; Li D; Rossi C; Fuller D; Fuller J; Haynes J; Huggins J
    J Virol; 1997 Dec; 71(12):9563-9. PubMed ID: 9371620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protective activity of a bacterial plasmid, bearing the gene for the tick-borne encephalitis virus NS1 nonstructural protein].
    Timofeev AV; Kondrat'eva IuIu; Karganova GG; Stephenson J
    Vopr Virusol; 2001; 46(1):22-4. PubMed ID: 11233282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.